XML 47 R35.htm IDEA: XBRL DOCUMENT v3.8.0.1
BUSINESS DESCRIPTION (Narrative) (Details)
 1 Months Ended 2 Months Ended 12 Months Ended
Mar. 28, 2018
USD ($)
Mar. 21, 2018
USD ($)
$ / shares
Mar. 12, 2018
USD ($)
Feb. 20, 2018
USD ($)
Feb. 12, 2018
USD ($)
shares
Jan. 08, 2018
USD ($)
Jan. 08, 2018
USD ($)
Jun. 29, 2017
$ / shares
Aug. 31, 2017
USD ($)
shares
Feb. 28, 2018
USD ($)
shares
Dec. 31, 2017
USD ($)
Dec. 31, 2016
USD ($)
Nov. 30, 2017
$ / shares
Jun. 30, 2016
$ / shares
Business Acquisition [Line Items]                            
Stock split and reverse stock split                     0.033      
Net loss                     $ 20,694,000 $ 2,227,000    
Accumulated Net Income (Loss)                     (20,700,000)      
Working deficiency                     8,300,000      
Net cash used in operating activities                     (6,690,000) $ (959,000)    
Issuance of warrants                 $ 84,000,000   7,784,000      
New shares issued (in shares) | shares                 22,518          
Warrants, exercise price per share | $ / shares                           $ 0.00
Crede [Member]                            
Business Acquisition [Line Items]                            
Loss contingency, damages sought                     $ 2,200,000      
Common Stock [Member]                            
Business Acquisition [Line Items]                            
Warrants, exercise price per share | $ / shares               $ 7.50            
Series C Preferred Stock [Member]                            
Business Acquisition [Line Items]                            
Warrants, exercise price per share | $ / shares                         $ 1.63  
Subsequent Events [Member]                            
Business Acquisition [Line Items]                            
Equity Purchase Agreement, Value                   $ 8,000,000        
Issuance of warrants         $ 1,900,000         $ 709,000        
New shares issued (in shares) | shares         1,814,754         721,153        
Subsequent Events [Member] | Crede Capital Group LLC [Member]                            
Business Acquisition [Line Items]                            
Loss contingency, damages sought     $ 1,800,000 $ 2,200,000                    
Litigation settlement in favor of other party, amount       $ 1,925,000                    
Subsequent Events [Member] | Convertible Preferred Stock [Member]                            
Business Acquisition [Line Items]                            
Proceeds from issuance of warrants $ 200,000 $ 200,000                        
Warrants, exercise price per share | $ / shares   $ 0.75                        
Connecticut Department of Economic and Community Development Laon [Member] | Subsequent Events [Member]                            
Business Acquisition [Line Items]                            
Proceeds from Grantors           $ 100,000 $ 100,000              
Secured debt           300,000 300,000              
Proceeds from grants and issuance of debt           $ 400,000 $ 400,000              
Debt instrument, term             10 years              
Transgenomics [Member]                            
Business Acquisition [Line Items]                            
Merger transaction, effective date               Jun. 29, 2017            
Merger transaction, agrement date               Oct. 12, 2016            
Merger transaction, name of acquired entity               Precipio Diagnostics, LLC, a privately held Delaware limited liability company            
Merger transaction, reverse stock split description               effected a 1-for-30 reverse stock split of its common stock            
Stock split and reverse stock split               30            
Merger transaction, pre-reverse stock split exchange ratio               10.2502